Phathom Pharmaceuticals (PHAT) EPS (Weighted Average and Diluted): 2022-2025
Historic EPS (Weighted Average and Diluted) for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to -$0.41.
- Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) rose 68.94% to -$0.41 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.77, marking a year-over-year increase of 34.43%. This contributed to the annual value of -$5.29 for FY2024, which is 34.61% down from last year.
- As of Q3 2025, Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.41, which was up 60.95% from -$1.05 recorded in Q2 2025.
- Over the past 5 years, Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at -$0.41 during Q3 2025, and registered a low of -$1.56 during Q2 2024.
- For the 3-year period, Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$1.09, with its median value being -$1.05 (2025).
- As far as peak fluctuations go, Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) tumbled by 85.71% in 2024, and later soared by 68.94% in 2025.
- Over the past 4 years, Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.33 in 2022, then fell by 9.02% to -$1.45 in 2023, then surged by 31.03% to -$1 in 2024, then skyrocketed by 68.94% to -$0.41 in 2025.
- Its last three reported values are -$0.41 in Q3 2025, -$1.05 for Q2 2025, and -$1.31 during Q1 2025.